Merit Medical Systems (NASDAQ:MMSI) Hits New 52-Week Low – What’s Next?

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) hit a new 52-week low on Tuesday . The company traded as low as $70.67 and last traded at $71.88, with a volume of 1189672 shares changing hands. The stock had previously closed at $72.66.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on MMSI shares. BTIG Research began coverage on shares of Merit Medical Systems in a research report on Friday, February 6th. They issued a “buy” rating and a $107.00 price objective on the stock. Piper Sandler dropped their target price on shares of Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. Needham & Company LLC cut their target price on shares of Merit Medical Systems from $108.00 to $101.00 and set a “buy” rating for the company in a research report on Wednesday, February 25th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Merit Medical Systems in a report on Monday, December 29th. Finally, Barrington Research increased their price target on shares of Merit Medical Systems from $106.00 to $109.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $103.33.

Merit Medical Systems Trading Down 1.1%

The firm has a market cap of $4.27 billion, a price-to-earnings ratio of 33.91, a price-to-earnings-growth ratio of 2.10 and a beta of 0.62. The business has a 50 day moving average of $81.87 and a 200 day moving average of $84.31. The company has a quick ratio of 2.95, a current ratio of 4.34 and a debt-to-equity ratio of 0.46.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.08. The firm had revenue of $393.94 million during the quarter, compared to the consensus estimate of $390.77 million. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The firm’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.93 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, research analysts forecast that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Merit Medical Systems

Several institutional investors and hedge funds have recently modified their holdings of MMSI. Ameritas Investment Partners Inc. boosted its position in Merit Medical Systems by 2.2% during the second quarter. Ameritas Investment Partners Inc. now owns 5,973 shares of the medical instruments supplier’s stock worth $558,000 after acquiring an additional 131 shares during the last quarter. Norden Group LLC raised its holdings in Merit Medical Systems by 5.7% in the 3rd quarter. Norden Group LLC now owns 2,536 shares of the medical instruments supplier’s stock valued at $211,000 after acquiring an additional 137 shares during the last quarter. Lido Advisors LLC lifted its stake in shares of Merit Medical Systems by 3.8% during the 4th quarter. Lido Advisors LLC now owns 3,836 shares of the medical instruments supplier’s stock worth $324,000 after purchasing an additional 140 shares during the period. Bryn Mawr Trust Advisors LLC lifted its stake in shares of Merit Medical Systems by 7.2% during the 2nd quarter. Bryn Mawr Trust Advisors LLC now owns 2,225 shares of the medical instruments supplier’s stock worth $208,000 after purchasing an additional 149 shares during the period. Finally, Hilltop National Bank boosted its holdings in shares of Merit Medical Systems by 8.7% during the third quarter. Hilltop National Bank now owns 2,119 shares of the medical instruments supplier’s stock worth $176,000 after purchasing an additional 169 shares during the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.